A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

The poster will be available on SELLAS websites following the session.

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...

Brain metastasis is emerging as the most serious concern for breast cancer patients. HER2-positive breast cancer is more prone to undergo brain metastasis than other subtypes; notably, there has been ...

Despite advancements in melanoma therapy, the prognosis remains unfavorable for many patients. The proteasome inhibitor MG132 has shown therapeutic potential through pathway regulation, yet its ...